Hossain, Md. Farhad, Hasana, Sharifa, Mamun, Abdullah Al, Uddin, Md. Sahab, Wahed, Mir Imam Ibne, Sarker, Sabarni, Behl, Tapan, Ullah, Irfan, Begum, Yesmin, Bulbul, Israt Jahan, Amran, Md. Shah, Rahman, Md. Habibur, Bin-Jumah, May N., Alkahtani, Saad, Mousa, Shaker A., Aleya, Lotfi and Abdel-Daim, Mohamed M. 2020. COVID-19 outbreak: pathogenesis, current therapies, and potentials for future management. Frontiers in Pharmacology 11 , 563478. 10.3389/fphar.2020.563478 |
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution. Download (2MB) | Preview |
Abstract
At the end of 2019, a novel coronavirus (CoV) was found at the seafood market of Hubei province in Wuhan, China, and this virus was officially named coronavirus diseases 2019 (COVID-19) by World Health Organization (WHO). COVID-19 is mainly characterized by severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) and creates public health concerns as well as significant threats to the economy around the world. Unfortunately, the pathogenesis of COVID-19 is unclear and there is no effective treatment of this newly life-threatening and devastating virus. Therefore, it is crucial to search for alternative methods that alleviate or inhibit the spread of COVID-19. In this review, we try to find out the etiology, epidemiology, symptoms as well as transmissions of this novel virus. We also summarize therapeutic interventions and suggest antiviral treatments, immune-enhancing candidates, general supplements, and CoV specific treatments that control replication and reproduction of SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV).
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Pharmacy |
Publisher: | Frontiers Media |
ISSN: | 1663-9812 |
Date of First Compliant Deposit: | 2 October 2024 |
Date of Acceptance: | 15 September 2020 |
Last Modified: | 02 Oct 2024 08:40 |
URI: | https://orca.cardiff.ac.uk/id/eprint/171616 |
Actions (repository staff only)
Edit Item |